about
Procarbazine, lomustine and vincristine for recurrent high-grade gliomaFingolimod for the treatment of neurological diseases-state of play and future perspectivesOvercoming therapeutic resistance in glioblastoma: the way forwardOdds of death after glioblastoma diagnosis in the United States by chemotherapeutic era.Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients.Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina.Prognostic Value of Metabolic Tumor Volume on (11)C-Methionine PET in Predicting Progression-Free Survival in High-Grade Glioma.Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids.Enhancing radiotherapy: breaking free from undue zeal for the existent, and utter contempt for the prospective.Procarbazine, lomustine and vincristine for recurrent high-grade glioma.99mTc-Tetrofosmin Uptake Correlates with the Sensitivity of Glioblastoma Cell Lines to Temozolomide.Insights into molecular therapy of glioma: current challenges and next generation blueprintThe Long and Winding Road: From the High-Affinity Choline Uptake Site to Clinical Trials for Malignant Brain Tumors.Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ).Modulated Radiotherapy with Concurrent and Adjuvant Temozolomide for Anaplastic Gliomas: Indian Single-center Data.Temozolomide with or without Radiotherapy in Patients with Newly Diagnosed Glioblastoma Multiforme: A Meta-Analysis.A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells.Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosisNatural borneol is a novel chemosensitizer that enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage
P2860
Q24187436-B1484997-B518-4899-8761-BE529F820D08Q27026175-E035AE60-F1B1-4182-9DD8-CD5CB48C2C1FQ29248396-AC294F3E-B6B2-427A-B2D1-C718E5A362ACQ33913598-8E149A63-D185-4AF2-ACAC-54677FE06236Q34785641-7D71EE78-69C6-4C1C-AF4A-7E4DE0E31714Q35708559-3C6A0394-EA8F-4C5B-ADD6-9C216F2D34E2Q35835743-5F4D8DF9-3333-475E-AF14-06E17615A252Q37730054-79FA7485-F28A-4DBE-8A5E-95533D437A4AQ38254040-965D64AC-BF6A-4161-800E-DE65632A7BF9Q38660976-23890AF3-8FE6-4991-8EEC-CE4905534051Q38715704-63062423-1682-4419-9A5C-1B8537ED7A37Q39187306-468C7663-BEC1-4BEA-8811-0BE3586D0424Q41189810-8AEE359D-D5E4-46EC-BB4F-B5033CF0291DQ47318878-FF24EC08-8B4D-44A6-9A42-83525EE67664Q47730217-6C4CA787-3274-49FF-B17D-987B279762CAQ47732901-2F968985-7299-4AD3-B2ED-9027D2BF6D9BQ48311392-59B17688-0CF7-4152-A3E3-AFC636AB2DA0Q55012542-DB43590E-1F5D-492B-9DF4-6238BC0D4470Q58755619-74A7B7C1-FB53-47F5-99C5-82004FA4B145Q58764959-EEA0821E-0301-49BB-AD96-53F7EA568915
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Temozolomide for high grade glioma
@ast
Temozolomide for high grade glioma
@en
Temozolomide for high grade glioma
@nl
type
label
Temozolomide for high grade glioma
@ast
Temozolomide for high grade glioma
@en
Temozolomide for high grade glioma
@nl
prefLabel
Temozolomide for high grade glioma
@ast
Temozolomide for high grade glioma
@en
Temozolomide for high grade glioma
@nl
P2093
P2860
P1476
Temozolomide for high grade glioma
@en
P2093
Gabriel Rogers
Robin Grant
Ruth Garside
P2860
P304
P356
10.1002/14651858.CD007415.PUB2
P577
2013-04-30T00:00:00Z